Redirect Notice
The previous page is sending you to
http://globenewswire.com/news-release/2015/10/08/774562/10151840/en/VBI-Vaccines-Announces-Development-of-a-Novel-Glioblastoma-Immunotherapy-Candidate.html
.
If you do not want to visit that page, you can
return to the previous page
.